Key result
Routine natriuretic peptide and echo screening is recommended to delay HF in high-risk patients with diabetes.
Why the study?
Heart failure frequently affects patients with type 2 diabetes, but early detection and diagnosis remain challenging for noncardiologist clinicians, leading to treatment delays and poor outcomes.
This educational podcast provides practical guidance for noncardiologist clinicians on identifying, screening, and managing heart failure in patients with diabetes.
Answers are grounded in this paper and cite their sources.
Noncardiologists should prioritize early HF detection in T2DM; reinforces its role as first CVD presentation in 22% of patients.
Heart failure is a growing major public health concern. Total medical costs for heart failure in the USA are expected to rise to more than US $70 billion by 2030, and this is expected to rise as the prevalence of heart failure increases owing to an aging population and the concurrent increase in risk factors for heart failure such as obesity, diabetes, and chronic kidney disease. Heart failure affects 22% of patients with type 2 diabetes and is frequently the first presentation of cardiovascular disease in these patients. One of the key challenges in heart failure treatment is early detection and diagnosis. Heart failure can present similarly to chronic obstructive pulmonary disease and is often misdiagnosed. Late diagnosis of heart failure can lead to delays in treatment initiation and poor patient outcomes. Clinicians other than specialist cardiologists, particularly endocrinologists and primary care physicians in the case of patients with diabetes, can play a key role in the early detection and diagnosis of heart failure. In this podcast series of three episodes, a cardiovascular specialist, an endocrinologist, and a primary care physician will provide practical guidance for primary care physicians on optimal identification and management of heart failure in patients with diabetes. In the first episode, we give a pragmatic overview of heart failure and practical guidance on how clinicians can identify patients most at risk of developing heart failure, tips for early detection and screening, and ultimately, how to prevent progression of heart failure in these patients. Podcast available for this article.
No takes yet. Share an insight, caveat, or question.
Desai et al. (2026) conducted an editorial in Heart failure in patients with diabetes. Routine screening with natriuretic peptides and echocardiography is recommended to facilitate the early detection and delay the progression of heart failure in high-risk patients with diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: